Sleep apnea events during REM sleep are linked to verbal memory impairment in older adults at risk for Alzheimer's disease. A new research highlights the importance of focusing on sleep-stage-specific apnea severity for accurate diagnosis and treatment.
Identifying people with Parkinson's disease (PD) in its prodromal phase has become a priority to open a window for disease-modifying therapies.
Next May 22nd will take place the Multiple Sclerosis Day for relatives and patients. The meeting will take place at the Menador Espai Cultural at 17h (Plaça de l'Hort dels Corders, 4, 12001 Castelló de la Plana, Castelló).
Cognitive impairment, affecting memory, concentration, learning, and decision-making, is prevalent among older adults, with around two-thirds experiencing some level of impairment after the age of 70. Ethnicity plays a role in cognitive dysfunction, with Black individuals at a higher risk compared to White individuals, along with other factors like...
A recent study conducted by UCLA Health suggests that a simple blood test could serve as an effective tool for determining an individual's susceptibility to stroke and cognitive decline later in life. Published in the journal Stroke, the study focused on measuring concentrations of inflammatory molecules in the blood to calculate a risk score for...
A recent study published in Neurology® Clinical Practice suggests a potential association between acid-reducing drugs and heightened risks of migraine and severe headaches.
A new study reveals a strong correlation between diet and brain health. Analyzing dietary data and health indicators from 181,990 UK Biobank participants, the study found that a balanced diet is crucial for cognitive function, mental well-being, and brain structure.
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford have analyzed data from participants in the UK Biobank to show that diabetes, traffic-related air pollution, and alcohol consumption are the most harmful factors out of 15 modifiable risk factors for dementia.
Prasinezumab, a monoclonal antibody targeting alpha-synuclein aggregation, shows promise in slowing motor deterioration in rapidly progressing Parkinson's disease (PD), according to an exploratory analysis from the phase 2 PASADENA clinical trial.
Green tea has become a popular beverage worldwide because of its health benefits, including antioxidant, antimicrobial, and cholesterol-lowering effects.
